Mechanisms of Heterosubtypic Immunity to Lethal Influenza A Virus Infection in Fully Immunocompetent, T Cell-Depleted, β2-Microglobulin-Deficient, and J Chain-Deficient Mice

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1222-1230

  Epstein, Suzanne L ^a   Lo, Chia Yun ^a   Misplon, Julia A ^a   Lawson, Cassandra M ^b,d   Hendrickson, Barbara A ^c   Max, Edward E ^a   Subbarao, Kanta ^b,e  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN J CHAIN; SECRETORY IMMUNOGLOBULIN; VIRUS ANTIBODY;

A J MOUSE; ANIMAL; ARTICLE; C57BL MOUSE; CYTOTOXICITY; FEMALE; IMMUNOLOGY; INFLUENZA VIRUS A; LUNG; LYMPHOCYTE DEPLETION; MALE; MICROBIOLOGY; MOUSE; MOUSE MUTANT; ORTHOMYXOVIRUS INFECTION; PASSIVE IMMUNIZATION; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; BETA 2-MICROGLOBULIN; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN J-CHAINS; INFLUENZA A VIRUS; LUNG; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED A; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTE SUBSETS; VIRUS REPLICATION;

EID: 0031066918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Schulman, J. L., and E. D. Kilbourne. 1965. Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. J. Bacteriol. 89:170.
2. Yetter, R. A., W. H. Barber, and P. A. Small, Jr. 1980. Heterotypic immunity to influenza in ferrets. Infect. Immun. 29:650.
3. Yetter, R. A., S. Lehrer, R. Ramphal, and P. A. Small, Jr. 1980. Outcome of influenza infection: effect of site of initial infection and heterosubtypic immunity. Infect. Immun. 29:654.
4. Mbawuike, I. N., H. R. Six, T. R. Cate, and R. B. Couch. 1990. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J. Virol. 64:1370.
5. Liang, S., K. Mozdzanowska, G. Palladino, and W. Gerhard. 1994. Heterosubtypic immunity to influenza type A virus in mice: effector mechanisms and their longevity. J. Immunol. 152:1653.
6. Taylor, P. M., and B. A. Askonas. 1986. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 53:417.
7. Askonas, B. A., A. J. McMichael, and R. G. Webster. 1982. The immune response to influenza viruses and the problem of protection against infection. In Basic and Applied Influenza Research. A. S. Beare, ed. CRC Press, Boca Raton, FL, p. 159.
8. Wraith, D. C., A. E. Vessey, and B. A. Askonas. 1987. Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68:433.
9. Tite, J. P., C. Hughes-Jenkins, D. O'Callaghan, G. Dougan, S. M. Russell, X.-M. Gao, and F. Y. Liew. 1990. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus: II. Protection from influenza infection and mechanism of protection. Immunology 71:202.
10. Andrew, M. E., and B. E. H. Coupar. 1988. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice. Scand. J. Immunol. 28:81.
11. Andrew, M. E., B. E. H. Coupar, D. B. Boyle, and G. L. Ada. 1987. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand. J. Immunol. 25:21.
12. Webster, R. G., Y. Kawaoka, J. Taylor, R. Weinberg, and E. Paoletti. 1991. Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9:303.
13. Webster, R. G., and V. S. Hinshaw. 1977. Matrix protein from influenza A virus and its role in cross-protection in mice. Infect. Immun. 17:561.
14. 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150:5484.
15. Lawson, C. M., J. R. Bennink, N. P. Restifo, J. W. Yewdell, and B. R. Murphy. 1994. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol. 68:3505.
16. Yap, K. L., T. J. Braciale, and G. L. Ada. 1979. Role of T-cell function in recovery from murine influenza infection. Cell. Immunol. 43:341.
17. + cytotoxic T cells. Immunology 67:375.
18. + T cells act as effector cells in protection against influenza virus infection? Immunology 62:139.
19. Mazanec, M. B., C. S. Kaetzel, M. E. Lamm, D. Fletcher, and J. G. Nedrud. 1992. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA 89:6901.
20. Mazanec, M. B., C. L. Coudret, and D. R. Fletcher. 1995. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69:1339.
21. Burns, J. W., M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104.
22. 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342:435.
23. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:317.
24. Hendrickson, B. A., D. A. Conner, D. J. Ladd, D. Kendall, J. E. Casanova, B. Corthesy, E. E. Max, M. R. Neutra, C. E. dman, and J. G. dman. 1995. Altered hepatic transport of immunoglobulin A in mice lacking the J chain. J. Exp. Med. 182:1905.
25. Kilbourne, E. D., B. E. Johansson, and B. Grajower. 1990. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc. Natl. Acad. Sci. USA 87:786.
26. Chen, K.-S., and G. V. Quinnan, Jr. 1988. Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines. J. Gen. Virol. 69:2779.
27. Smith, G. L., J. Z. Levin, P. Palese, and B. Moss. 1987. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336.
28. Earl, P. L., N. Cooper, and B. Moss. 1991. Preparation of cell cultures and vaccinia virus stocks. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. dman, J. A. Smith, and K. Struhl, eds. John Wiley & Sons, New York, p. 16.16.1.
29. van Wyke, K. L., V. S. Hinshaw, W. J. Bean, Jr., and R. G. Webster. 1980. Antigenic variation of influenza A virus nucleoprotein detected with monoclonal antibodies. J. Virol. 35:24.
30. Snyder, M. H., R. F. Betts, D. DeBorde, E. L. Tierney, M. L. Clements, D. Herrington, S. D. Sears, R. Dolin, H. F. Maassab, and B. R. Murphy. 1988. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J. Virol. 62:488.
31. Centers for Disease Control. 1975. Advanced laboratory techniques for influenza diagnosis. Atlanta, p. 25.
32. Flexner, C., B. R. Murphy, J. Rooney, C. Wohlenberg, V. Yuferov, A. Notkins, and B. Moss. 1988. Successful vaccination with a polyvalent live vector despite immunity to expressed antigens. Nature 335:259.
33. + T cells, while that induced by VAC-F or VAC-G recombinants is mediated by antibodies. J. Virol. 66:1277.
34. Buller, R. M. L., K. L. Holmes, A. Hügin, T. N. Frederickson, and H. C. Morse III. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77.
35. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:623.
36. + T cells. J. Immunol. 144:3980.
37. Epstein, S. L., C.-Y. Lo, J. A. Misplon, B. R. Murphy, C. M. Lawson, and E. K. Subbarao. 1995. Mediators of heterosubtypic immunity to influenza A virus infection in mice. In Vaccines '95: Molecular Approaches to the Control of Infectious Diseases. Cold Spring Harbor Laboratory Press, Plainview, NY, p. 393.
38. 2-microglobulin. MHC class I-deficient mice. Proc. Natl. Acad. Sci. USA 90:2837.
39. 2-microglobulin-deficient mice. J. Immunol. 153:595.
40. Murphy, B. R., and R. G. Webster. 1990. Orthomyxoviruses. In Virology, 2nd Ed. B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman, eds. Raven Press, New York, p. 1091.
41. Steinhoff, M. C., L. F. Fries, R. A. Karron, M. L. Clements, and B. R. Murphy. 1993. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. J. Infect. Dis. 31:836.
42. Sonoguchi, T., H. Naito, M. Hara, Y. Takeuchi, and H. Fukumi. 1985. Cross-subtype protection in humans during sequential overlapping and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J. Infect. Dis. 151:81.
43. Bender, B. S., W. E. Bell, S. Taylor, and P. A. Small, Jr. 1994. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza. J. Infect. Dis. 170:1195.
44. + T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA 89:6070.
45. 2-microglobulin-deficient mice. Science 255:1576.
46. Fung-Leung, W.-P., T. M. Kündig, R. M. Zinkernagel, and T. W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CDS expression. J. Exp. Med. 174:1425.
47. + T cell depletion. Reg. Immunol. 5:142.
48. Suda, T., A. Sato, W. Sugiura, and K. Chida. 1995. Induction of MHC class II antigens on rat bronchial epithelial cells by interferon-γ and its effect on antigen presentation. Lung 173:127.
49. Ibrahim, L., M. Dominguez, and M. Yacoub. 1993. Primary human adult lung epithelial cells in vitro: response to interferon-γ and cytomegalovirus. Immunology 79:119.
50. + T cells. J. Exp. Med. 172:1225.
51. + T cells: a new family of T cells. Immunol. Today 17:71.
52. Waldmann, T. A., and W. Strober. 1969. Metabolism of immunoglobulins. Prog. Allergy 13:1.
53. Mestecky, J., and J. R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153.
54. Hendrickson, B. A., L. Rindisbacher, B. Corthesy, D. Kendall, D. A. Waltz, M. R. Neutra, and J. G. dman. 1996. Lack of association of secretory component with IgA in J chain-deficient mice. J. Immunol. 157:750.
55. Lemaitre-Coelho, I., M. Yamakido, P. C. Montgomery, A. E. Langendries, and J. P. Vaerman. 1982. Selective excretion of IgA in rat bronchial secretion: lack of significant contribution from plasma IgA. Immunol. Commun. 11:441.
56. Mazanac, M. B., J. G. Nedrud, X. Liang, and M. E. Lamm. 1989. Transport of serum IgA into murine respiratory secretions and its implications for immunization strategies. J. Immunol. 142:4275.
57. Renegar, K. B., and P. A. Small. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972.
58. Levi, R., and R. Arnon. 1996. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine 14:85.
59. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
60. Donnelly, J. J., A. Friedman, D. Martinez, D. L. Montgomery, J. W. Shiver, S. L. Motzel, J. B. Ulmer, and M. A. Liu. 1995. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:583.